nVerses Capital, LLC
Position in ARCT — Arcturus Therapeutics Holdings Inc.
CIK 2011399
WELLINGTON, FL
Position in ARCT
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$261,744
-$33,437 QoQ
Shares Held
38,950
+1.9% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#46
of 133 holders
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026nVerses Capital, LLC holds $6,104,017 across 30 Biotechnology names. ARCT ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
3,822 | $447,441 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
4,494 | $366,575 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
13,951 | $335,940 | |
| 4 | KURA |
Kura Oncology, Inc.
|
26,023 | $285,472 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,141 | $274,946 | |
| 6 | ARCT |
Arcturus Therapeutics Holdings Inc.
This page
|
38,950 | $261,744 | |
| 7 | SMMT |
Summit Therapeutics Inc.
|
17,749 | $258,602 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
26,117 | $256,468 |
All Filings in ARCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,744 | 38,950 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $295,181 | 38,236 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $140,401 | 22,904 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $41,778 | 1,800 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||